Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Propofol
Dechra Regulatory B.V.
QN01AX10
Propofol
10.0 milligram(s)/millilitre
Emulsion for injection/infusion
POM: Prescription Only Medicine as defined in relevant national legislation
propofol
Authorised
2019-06-28
Health Products Regulatory Authority 03 April 2020 CRN009P7K Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Propodine 10 mg/ml emulsion for injection/infusion for dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Propofol 10.0 mg EXCIPIENT(S): For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Emulsion for injection/infusion. White or almost white homogeneous emulsion. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES - General anaesthesia for diagnostic or surgical procedures of short duration, lasting up to five minutes. - Induction and maintenance of general anaesthesia. - Induction of general anaesthesia where maintenance is provided by inhalation anaesthetic agents. 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES This product is a stable emulsion. Prior to use, the product should be inspected visually for the absence of visible droplets or extraneous foreign particles and discarded if present. Do not use if evidence of phase separation remains after gentle shaking. If the product is injected too slowly, an inadequate plane of anaesthesia can occur, due to failure to reach the appropriate threshold of pharmacological activity. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals During induction of anaesthesia, mild hypotension and transient apnoea may occur. If the product is injected too rapidly, cardiopulmonary depression may occur (apnoea, bradycardia, hypotension). When using the veterinary medicinal product, facilities for the maintenance of a patent airway, artificial ventilation and oxygen enrichment must be available. Following induction of anaesthesia, the use of an endotracheal tube is recommended. It is advisable to administer supplemental oxygen during maintenance of anaesthesia. Caution s Read the complete document